Effect of simvastatin therapy on blood and tissue ATP levels and erythrocyte membrane lipid composition

Research in Experimental Medicine

Volumn 199, Issue 4, 2000, Pages 189-194

  Caliskan S ^a   Caliskan M ^a   Kuralay, F ^a   Onvural B ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

ATP; Cholesterol; Simvastatin

Indexed keywords

ADENOSINE TRIPHOSPHATE; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; MEMBRANE PHOSPHOLIPID; MEVALONIC ACID; SIMVASTATIN; TRIACYLGLYCEROL; UBIQUINONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ERYTHROCYTE MEMBRANE; FEMALE; LIPID COMPOSITION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN; TISSUE LEVEL;

ADENOSINE TRIPHOSPHATE; ANIMALS; CHOLESTEROL; COLORIMETRY; ERYTHROCYTE MEMBRANE; FEMALE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPIDS; MALE; RATS; SIMVASTATIN; STATISTICS, NONPARAMETRIC;

EID: 0034003456     PISSN: 03009130     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. 1. Adam H (1974) Adenosine-5′-triphosphate determination with phosphogylcerate kinase. In: Bergmeyer HU (ed) Methods of enzymatic analysis, 3rd edn. Academic, New York, p 2127
2. 2. Bucher HC, Griffith LE, Guyatt GH (1999) Systematic review on the risk and benefit of different cholesterol-lowering intervations. Arterioscler Thromb Vasc Biol 19:187-195
3. 3. Conrad BB (1994) Comparison of properties of four inhibitors on 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Am J Cardiol 73:3D-11D
4. 4. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM (1998) Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. Results of AFCAPS/TexCAPS. JAMA 279:1615-1622
5. 5. Dursun M, Burke JG, Areveley M (1994) Low serum cholesterol and depression. BMJ 309:273-274
6. 6. Dwight FS, Riberio ACM, Hendry BM (1996) Effects of HMG CoA reductase inhibition on erythrocyte membrane cholesterol and acyl chain composition. Clin Chim Acta 256:53-63
7. 7. Folch J, Lees M, Stanley GHS (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509
8. 8. Goldstein JL, Brown MS (1990) Regulation of the mevalonate pathway. Nature 343:425-430
9. 9. Herrinton J, Friedman GD (1995) Serum cholesterol concentration and risk of brain cancer. BMJ 310:367-368
10. + ATPase activity can be a marker of liver histopathology. Biochem Mol Bio Int 40(4):769-777
11. 11. Laaksonen R, Jokelainen K, Laakso J, Sahi T, Harkonen M, Tikkanen MJ, Himberg J (1996) The effect of simvastatin treatment on natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscle. Am J Cardiol 77:851-854
12. 12. Law M (1996) Commentary: having too much evidence (depression, suicide and low serum cholesterol). BMJ 313:651-652
13. 13. Levy Y, Leibowitz R, Aviram M, Brook JG, Cogan U (1992) Reduction in plasma cholesterol by lovastatin normalises erythrocyte membrane fluidity in patients with severe hypercholesterolemia. Br J Clin Pharmacol 34:427-430
14. 14. Lijnen P, Celis H, Fagard H, Staessen J, Amery A (1994) Influence of cholesterol lowering on plasma lipids and cations transport mechanisms. J Hypertens 12:59-64
15. 15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1981) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
16. 16. MacMahon S, Sharpe N, Gamble G, Hart H, Scott J, Simes J, White H (1998) Effects of lowering average or below-average cholesterol levels on the progression of carotid atherosclerosis. Results of the LIPID atherosclerosis substudy. Circulation 97:1784-1790
17. 17. Manoukian AA, Bhagavan NV, Hayashi TA, Nestor T, Ribos C, Scottolini AG (1990) Rhabdomyolysis secondary to lovastatin therapy. Clin Chem 36(12): 2145-2147
18. 18. Nakahara K, Kuriyama M, Sonoda Y, Yoshidome H, Nagagava H, Fujiyama J, Higuchi I, Osame M (1998) Myopathy induced by HMG-CoA reductase inhibitors in rabbits: a pathological, electrophysiological, and biochemical study. Toxicol Appl Pharamcol 152:99-106
19. 19. Pfeffer MA, Sacks FM, Moye LA, East C, Goldman S, Nash DT, Rouleau JR, Rouleau JC, Sussex BA, Theroux P, Vanden Belt RJ, Braunvald E (1999) Influence of baseline lipids on effectiveness of pravastatin in the CARE trial. J Am Coll Cardiol 33:125-130
20. 20. Pierno S, DeLuca A, Tricarico D, Roselli A, Natuzzi F, Ferrannini E, Leico M, Camerino DC (1995) Potential risk of myopathy by HMG CoA reductase inhibitors: a comparison of pravastatin and simvastatin effects on membrane electrical properties of rat skeletal muscle fibers. J Pharmacol Exp Ther 275:1490-1496
21. 21. Ploeckinger B, Dantendorfer K, Ulm M, Baischer W, Derfler K, Musalek M, Christian D (1996) Rapid decrease of serum cholesterol concentration and postpartum depression. BMJ 313:664
22. 22. Rosenberg AD, Neuwirth MG, Kagen LJ, Singh K, Fischer HD, Bernstein LD (1995) Intraoperative rhabdomylysis in a patient receiving pravastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A (HMG CoA) reductase inhibitor. Anesth Analg 81: 1089-1091
23. 23. Smith PF, Eydelloth RS, Grossman SJ, Stubbs J, Schwartz MS, Germershausen JI, Kamlesh PV, Prasad HK, MacDonald JS (1991) HMG CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies. J Pharmacol Exp Ther 257:1225-1235
24. 24. Smith PF, Eydelloth RS, Grossman SJ, Stubbs RJ, Schwartz MS, Germeshausen JI, MacDonald JS (1992) Myopathy associated with HMG CoA reductase inhibitor (HMGRIS) and cyclosporin A: evaluation in a rat model. Eur Heart 13B:2-6
25. 25. Steegmans HA, Fekkes D, Hoes AW, Bak AA, Does E, Grobbee DE (1996) Low serum cholesterol concentration and serotonin metabolism in men. BMJ 312:221
26. 26. Wannamathee G, Shaper AG, Wincup PH, Walker M (1995) Low serum total cholesterol concentrations and mortality in middle aged British men. BMJ 311:409-413
27. 27. Watts GF, Castelluccio C, Rice-Evans C, Taub NA, Baum H, Quinn PJ (1993) Plasma Coenzyme Q (ubiquinone) concentrations in patients treated with simvastatin. J Clin Pathol 46:1055-1057
28. + activated erythrocyte adenosine triphosphatase. J Lab Clin Med 70:284-294
29. 29. Zureik M, Courbon D, Ducimetiere P (1996) Serum cholesterol concentration and death from suicide in men: Paris prospective study 1. BMJ 313:649-651